Matthew Lindquist
Psychiatric/Mental Health · St Louis, MONPI 1710969159
Payments from drug & device makers
Across 700 payments — averaging $60.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$27K
- Teva Pharmaceuticals USA, Inc.$4K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$3K
- Alkermes, Inc.$2K
- Neurocrine Biosciences, Inc.$1K
- Sunovion Pharmaceuticals Inc.$920
- plus $5K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 134 | $26,733 |
| Teva Pharmaceuticals USA, Inc. | 84 | $3,884 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 138 | $2,537 |
| Alkermes, Inc. | 51 | $1,614 |
| Neurocrine Biosciences, Inc. | 48 | $1,209 |
| Sunovion Pharmaceuticals Inc. | 61 | $920 |
| Johnson & Johnson(2 entities) | 31 | $786 |
| Validus Pharmaceuticals LLC | 8 | $737 |
| AbbVie | 36 | $639 |
| Vanda Pharmaceuticals Inc. | 14 | $601 |
| Axsome Therapeutics, Inc. | 11 | $584 |
| Lundbeck LLC | 27 | $372 |
| Noven Therapeutics, LLC | 24 | $324 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $191 |
| Livanova USA, Inc. | 2 | $170 |
| AstraZeneca | 2 | $165 |
| Indivior Inc. | 10 | $161 |
| Acadia Pharmaceuticals Inc | 1 | $125 |
| Neurelis, Inc. | 1 | $122 |
| E.r. Squibb & Sons, L.L.C. | 1 | $121 |
| Orexo US, Inc. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Noven Pharmaceuticals, Inc. | 2 | $45 |
| Bayer | 2 | $43 |
| Almatica Pharma LLC | 2 | $41 |
| Bioxcel Therapeutics, Inc. | 1 | $21 |
How this compares
$42,244 in reported general payments places this provider in the 95th percentile of 565 psychiatric/mental health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatric/mental health in St Louis
- M Susan DawsonSt Louis$8K
- Gina SettleSt Louis$6K
- Aldijana SacicSaint Louis$510K
- Erin DuvallSpringfield$275K
- Laurel OwensLees Summit$246K
- Julie WaterburySaint Louis$135K
- Emily WoukSpringfield$90K
- Kristerpher BrimberryPoplar Bluff$74K
- Stacy EmersonKennett$25K
- Jeffery DavisCreve Coeur$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.